Search Results - "Ito, Mutsumi"
-
1
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
Published in The New England journal of medicine (05-01-2023)“…Neither bebtelovimab nor any mAb combinations tested neutralized the SARS-CoV-2 omicron subvariants BQ.1.1 and XBB, but remdesivir, molnupiravir, and…”
Get full text
Journal Article -
2
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
Published in The New England journal of medicine (04-08-2022)“…In this study, investigators who were evaluating in vitro neutralization of omicron subvariants by monoclonal antibodies and antiviral drugs found considerable…”
Get full text
Journal Article -
3
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
Published in The New England journal of medicine (14-04-2022)“…The in vitro activity of monoclonal antibodies and antiviral agents was assessed against the sublineages of the SARS-CoV-2 variant of concern omicron (BA.1,…”
Get full text
Journal Article -
4
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
Published in The New England journal of medicine (10-03-2022)“…Investigators assessed the in vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19 variants of concern. All the…”
Get full text
Journal Article -
5
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Published in Proceedings of the National Academy of Sciences - PNAS (14-07-2020)“…At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around…”
Get full text
Journal Article -
6
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
Published in Nature (London) (15-12-2022)“…The BA.2 sublineage of the SARS-CoV-2 Omicron variant has become dominant in most countries around the world; however, the prevalence of BA.4 and BA.5 is…”
Get full text
Journal Article -
7
Favorite Parts of a Single Leaf for Giant Flying Squirrels to Eat in Three Species of Food Trees
Published in Biology (Basel, Switzerland) (01-10-2023)“…To examine the effect of leaf chemical composition on selective herbivory by the Japanese giant flying squirrels (Petaurista leucogenys), we measured and…”
Get full text
Journal Article -
8
Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
Published in The New England journal of medicine (29-09-2022)“…In vitro assessment of the susceptibility of BA.2.75 to approved antibodies and antivirals showed neutralizing efficacy by bebtelovimab and…”
Get full text
Journal Article -
9
Comparison of Rapid Antigen Tests for COVID-19
Published in Viruses (10-12-2020)“…Reverse transcription-quantitative PCR (RT-qPCR)-based tests are widely used to diagnose coronavirus disease 2019 (COVID-19). As a result that these tests…”
Get full text
Journal Article -
10
Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans
Published in Emerging infectious diseases (01-04-2018)“…To clarify the threat posed by emergence of highly pathogenic influenza A(H7N9) virus infection among humans, we characterized the viral polymerase complex…”
Get full text
Journal Article -
11
Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
Published in Journal of virology (23-02-2022)“…Despite various attempts to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with COVID-19 convalescent plasmas, neither…”
Get full text
Journal Article -
12
A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets
Published in Cell host & microbe (08-11-2017)“…Low pathogenic H7N9 influenza viruses have recently evolved to become highly pathogenic, raising concerns of a pandemic, particularly if these viruses acquire…”
Get full text
Journal Article -
13
Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene
Published in Cell host & microbe (10-10-2018)“…Discovery and characterization of broadly neutralizing antibodies (bnAbs) to the influenza hemagglutinin (HA) stem have provided insights for the development…”
Get full text
Journal Article -
14
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
Published in The Lancet infectious diseases (01-05-2023)“…[...]we assessed the efficacy of therapeutic monoclonal antibodies against a clinical isolate of omicron CH.1.1 (the sequence is registered with the Global…”
Get full text
Journal Article -
15
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
Published in The New England journal of medicine (01-12-2022)“…Researchers report that antiviral agents remdesivir, molnupiravir, and nirmatrelvir and monoclonal antibodies bebtelovimab and imdevimab retain effectiveness…”
Get full text
Journal Article -
16
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Published in EClinicalMedicine (01-02-2021)“…To develop an effective vaccine against a novel viral pathogen, it is important to understand the longitudinal antibody responses against its first infection…”
Get full text
Journal Article -
17
A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols
Published in mSphere (27-04-2022)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and…”
Get full text
Journal Article -
18
Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A viruses
Published in Journal of general virology (01-10-2019)“…Long-term culture of the human lung adenocarcinoma cell line A549 promotes the differentiation of these cells toward an alveolar type II cell phenotype. Here,…”
Get full text
Journal Article -
19
Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo
Published in Cell reports (Cambridge) (26-12-2023)“…EG.5.1 is a subvariant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB variant that is rapidly increasing in prevalence…”
Get full text
Journal Article -
20
Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens
Published in PLoS pathogens (01-12-2021)“…Regulatory T (Treg) cells, which constitute about 5-10% of CD4+T cells expressing Foxp3 transcription factor and CD25(IL-2 receptor α chain), are key…”
Get full text
Journal Article